Stock Analiz

ImmunityBio, Inc. (IBRX) stock forecast and price target

Price $6.02 · data as of November 13, 2026

12-month price target

Average target$14.25
Upside / downside+136.7%
Analysts4
ConsensusStrong buy
Low $12.00Average $14.25High $16.00

Gold marker: average target · white marker: today’s price ($6.02)

Analyst ratings

Strong buy 1Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.93−144.7%$202M
Next fiscal year
ends December 31, 2027
$-0.36—$352M
Quarter after
ends March 31, 2027
$-0.08+4.8%$69M

Consensus of the analysts covering ImmunityBio, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the ImmunityBio stock price target?

The average 12-month target from 4 analysts is $14.25, 136.7% above the current price of $6.02 Targets range from $12.00 to $16.00.

Is ImmunityBio a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is ImmunityBio expected to earn?

Analysts expect EPS of $-0.93 for the fiscal year ending December 31, 2026 and $-0.36 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.